CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

PCI Pharma Services

Wayne Hull, Chief Digital & Technology Officer

Driving Digital Transformation in the Pharma Industry

Wayne Hull

Wayne Hull

The healthcare industry is highly regulated and as a result, has been slow to change and embrace new technology. At PCI, a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, we see ourselves as pioneers who are challenging the status quo. We are looking ahead to the future and see the huge potential that digitization holds for the pharmaceutical supply chain. We are now a year into a three-year corporate digital transformation strategy and have made great progress. Below are some of the factors contributing to our early success:


• Listen and Learn: We’ve taken a novel approach to forming our strategy by listening to what our clients want, and using this feedback to guide the path forward. Through a number of client conversations and workshops, we’ve identified important areas of focus. Given our shared purpose to bring life-changing therapies to patients faster, our clients were more than willing to engage with us in this way.


• Set Focused Goals and a Roadmap to Get There: To meet the future needs of our global client base, we established three very clear objectives. They are: enhance customer experiences, digitize core business processes to achieve collaboration and efficiencies, and align IT capabilities for scale. The goals are based on extensive research around the pharmaceutical supply chain industry and digital trends. We also implemented an innovative internal design-thinking process to stimulate ideas from our teams for specific “value initiatives” that would ladder back to these goals. A few examples of these initiatives include a new digital client platform, business process digitization, and electronic quality management.


• Invest in Technologies and Talent: When our CEO Salim Haffar joined PCI in September 2018, he saw an opportunity to take a progressive approach to the way we work and create an industry-leading client experience through digitization. 


His vision was to invest in both talent and emerging technologies to improve our core business operations and create even more value for clients. While technologies like cloud, cyber security, big data, digital[1]marketing and robotics are key to the changes we want to make, seasoned talent to implement these changes is just as critical. As such, we have made new hires and brought the marketing, digital and technology functions closer together, reporting under one structure and working across traditional silos.


Change is never easy, especially in a conservative industry. Employees and clients alike need to be supported to adopt new systems and technologies


• Encourage Clients and Employees to Embrace Change: Change is never easy, especially in a conservative industry. Employees and clients alike need to be supported to adopt new systems and technologies. There needs to a top-down approach with clear and transparent communications about the strategy so stakeholders understand the bigger picture and the benefits they will ultimately realize. Leadership needs to layout what employees can expect in the future and how the organization will support them with training for new software, platforms, etc. Likewise, the organization needs to be prepared to train clients and may need to take a phased approach so it’s manageable.


As we continue in our digital transformation journey at PCI, we are building evidence that our investments are providing real and measurable returns. As a result, we are more confident to leverage new innovations and implement emerging technologies sooner. This is an exciting process and our ability to evolve quickly and propose even more novel solutions is what will continue to differentiate PCI in this industry.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://clinical-stage-biopharmaceutical.lifesciencesreview.com/leadership-perspective/driving-digital-transformation-in-the-pharma-industry-nwid-771.html